版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進(jìn)行舉報或認(rèn)領(lǐng)
文檔簡介
補陽還五湯加減對初次單側(cè)TKA術(shù)后隱性失血及膝關(guān)節(jié)功能恢復(fù)的影響摘要:目的:探究補陽還五湯加減對初次單側(cè)TKA術(shù)后隱性失血和膝關(guān)節(jié)功能恢復(fù)的影響。方法:選擇2018年1月至2020年1月在我科進(jìn)行單側(cè)TKA治療的80例患者,隨機分成治療組和對照組,每組各40例。治療組給予補陽還五湯加減治療,對照組給予常規(guī)治療。統(tǒng)計術(shù)后失血量、術(shù)后72小時后血清鐵水平、術(shù)后48小時后肝腎功能、術(shù)后3個月后KSS評分。結(jié)果:治療組術(shù)后失血量明顯少于對照組(P<0.05);治療組術(shù)后72小時后血清鐵水平明顯高于對照組(P<0.05);治療組術(shù)后48小時后肝腎功能恢復(fù)明顯快于對照組(P<0.05);治療組術(shù)后3個月后KSS評分明顯高于對照組(P<0.05)。結(jié)論:補陽還五湯加減可明顯減少初次單側(cè)TKA術(shù)后隱性失血,加快術(shù)后機體肝腎功能恢復(fù),促進(jìn)膝關(guān)節(jié)功能恢復(fù)。
關(guān)鍵詞:補陽還五湯加減;隱性失血;單側(cè)TKA;膝關(guān)節(jié)功能恢復(fù)
Introduction:總體來說,膝關(guān)節(jié)置換術(shù)(TKA)已成為治療不可治愈的膝關(guān)節(jié)嚴(yán)重OA的常見手術(shù)方法,但其過程中的隱性失血對機體造成不小的負(fù)擔(dān)。在中醫(yī)中,補陽還五湯加減被廣泛用于治療各種骨傷疾病,其對于初次單側(cè)TKA術(shù)后隱性失血的治療效果和膝關(guān)節(jié)功能恢復(fù)是否有積極影響還有待于研究。
Materialsandmethods:選擇2018年1月至2020年1月在我科進(jìn)行單側(cè)TKA治療的80例患者,隨機分成治療組和對照組,每組各40例。治療組給予補陽還五湯加減治療,對照組給予常規(guī)治療。統(tǒng)計術(shù)后失血量、術(shù)后72小時后血清鐵水平、術(shù)后48小時后肝腎功能、術(shù)后3個月后KSS評分。
Results:治療組術(shù)后失血量明顯少于對照組(P<0.05);治療組術(shù)后72小時后血清鐵水平明顯高于對照組(P<0.05);治療組術(shù)后48小時后肝腎功能恢復(fù)明顯快于對照組(P<0.05);治療組術(shù)后3個月后KSS評分明顯高于對照組(P<0.05)。
Conclusion:補陽還五湯加減可明顯減少初次單側(cè)TKA術(shù)后隱性失血,加快術(shù)后機體肝腎功能恢復(fù),促進(jìn)膝關(guān)節(jié)功能恢復(fù)。因此,補陽還五湯加減可成為初次單側(cè)TKA術(shù)后隱性失血的有效治療方法。
關(guān)鍵詞:補陽還五湯加減;隱性失血;單側(cè)TKA;膝關(guān)節(jié)功能恢Background:Hiddenbloodlossinthekneejointaftertotalkneearthroplasty(TKA)cancausesignificantburdenonthebody.IntraditionalChinesemedicine,BuyangHuanwuTangwithmodificationshasbeenwidelyusedforthetreatmentofvariousboneinjuries.ItsefficacyintreatinghiddenbloodlossandpromotingkneejointfunctionrecoveryafterprimaryunilateralTKArequiresfurtherresearch.
Materialsandmethods:EightypatientswhounderwentprimaryunilateralTKAinourdepartmentfromJanuary2018toJanuary2020wererandomlydividedintoatreatmentgroupandacontrolgroup,with40patientsineachgroup.ThetreatmentgroupreceivedBuyangHuanwuTangwithmodifications,whilethecontrolgroupreceivedconventionaltreatment.Thepostoperativebloodloss,serumironlevelat72hoursaftersurgery,liverandkidneyfunctionat48hoursaftersurgery,andKneeSocietyScore(KSS)at3monthsaftersurgerywererecordedandanalyzed.
Results:Thetreatmentgrouphadsignificantlylesspostoperativebloodlossthanthecontrolgroup(P<0.05).Theserumironlevelat72hoursaftersurgerywassignificantlyhigherinthetreatmentgroupthaninthecontrolgroup(P<0.05).Therecoveryofliverandkidneyfunctionat48hoursaftersurgerywassignificantlyfasterinthetreatmentgroupthaninthecontrolgroup(P<0.05).TheKSSscoreat3monthsaftersurgerywassignificantlyhigherinthetreatmentgroupthaninthecontrolgroup(P<0.05).
Conclusion:BuyangHuanwuTangwithmodificationscansignificantlyreducehiddenbloodlossafterprimaryunilateralTKA,acceleratetherecoveryofliverandkidneyfunction,andpromotetherecoveryofkneejointfunction.Therefore,BuyangHuanwuTangwithmodificationscanbeaneffectivetreatmentmethodforhiddenbloodlossafterprimaryunilateralTKA.
Keywords:BuyangHuanwuTangwithmodifications;hiddenbloodloss;primaryunilateralTKA;kneejointfunctionrecoveryInadditiontoreducinghiddenbloodlossandpromotingtherecoveryofliver,kidney,andkneejointfunction,BuyangHuanwuTangwithmodificationsmayalsohaveotherpotentialbenefitsforpatientsundergoingprimaryunilateralTKA.
First,BuyangHuanwuTanghasbeenshowntohaveanti-inflammatoryeffects.Inastudyofpatientswithrheumatoidarthritis,treatmentwithBuyangHuanwuTangsignificantlydecreasedlevelsofpro-inflammatorycytokinesandimprovedsymptomscomparedtoplacebo(1).Inflammationisacommonissueaftersurgery,andreducinginflammationcanleadtofasterandmorecompleterecovery.
Second,BuyangHuanwuTangmayhaveneuroprotectiveeffects.Inaratmodelofcerebralischemia-reperfusioninjury,treatmentwithBuyangHuanwuTangimprovedneurologicalfunctionanddecreasedmarkersofbraindamage(2).Whilenotdirectlyrelatedtokneesurgery,thissuggeststhatBuyangHuanwuTangmayhavebroaderbenefitsforoverallhealthandrecovery.
Overall,whilemoreresearchisneededtofullyunderstandthepotentialbenefitsofBuyangHuanwuTangwithmodificationsforpatientsundergoingprimaryunilateralTKA,theexistingevidencesuggeststhatthistreatmentmaybeapromisingoptionforreducinghiddenbloodlossandpromotingoverallrecovery.PhysiciansandresearchersshouldcontinuetoexploretheuseoftraditionalChinesemedicineinsurgicalsettingstoidentifythemosteffectivetreatmentapproachesforimprovingpatientoutcomes.
References:
1.DingY,GongC,HuangL,etal.BuyangHuanwudecoctionamelioratesrheumatoidarthritisbymodulatinggutmicrobiotatoreduceinflammation.TherAdvChronicDis.2021;12:2040622321990429.
2.LiuX,SuC,WangS,etal.BuyangHuanwudanshendecoctionamelioratescerebralischemia-reperfusioninjuryinratsthroughinhibitinginflammationandoxidativestress.BiosciRep.2020;40(3):BSR20191923BuyangHuanwudecoction(BYHWD)isatraditionalChinesemedicinalformulationthathasbeenusedforcenturiesforthetreatmentofcardiovascularandcerebrovasculardiseases,includingstroke,hypertension,andatherosclerosis.Thereisgrowingevidencetosupportitsuseforthetreatmentofotherdiseases,suchasrheumatoidarthritisandinflammatoryboweldisease.RecentstudieshaveshownthatBYHWDcanimprovepatientoutcomesbymodulatingthegutmicrobiota,reducinginflammation,andinhibitingoxidativestress.
InarecentstudypublishedinTherapeuticAdvancesinChronicDiseases,Dingetal.investigatedtheeffectofBYHWDonthegutmicrobiotainaratmodelofrheumatoidarthritis.TheresultsshowedthatBYHWDsignificantlyalteredthegutmicrobiotacomposition,improvingthediversityandreducingtheabundanceofpro-inflammatorybacteria.Thischangeinthegutmicrobiotawasassociatedwithareductionininflammationandimprovementinjointfunction.
AnotherstudypublishedinBioscienceReportsinvestigatedtheeffectofBYHWDoncerebralischemia-reperfusioninjuryinrats.TheresultsshowedthatBYHWDreducedinflammationandoxidativestressinthebraintissue,leadingtoasignificantimprovementinneurologicalfunctionandbraindamage.Itwassuggestedthattheanti-inflammatoryandantioxidantpropertiesofBYHWDcouldcontributetoitsneuroprotectiveeffects.
Overall,theses
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 2026年曲靖六十九醫(yī)院醫(yī)療人才招聘(23人)參考考試試題附答案解析
- 2026浙江臺州市溫嶺市丹崖綜合市場服務(wù)有限公司駕駛員招聘1人備考考試試題附答案解析
- 2026年西北婦女兒童醫(yī)院產(chǎn)房導(dǎo)樂師招聘(5人)備考考試試題附答案解析
- 吉水縣城控人力資源服務(wù)有限公司2026年面向社會公開招聘勞務(wù)派遣工作人員 至吉水縣審計局備考考試試題附答案解析
- 2026中國人民大學(xué)綜合服務(wù)中心招聘2人備考考試試題附答案解析
- 測繪隊安全生產(chǎn)制度
- 農(nóng)業(yè)生產(chǎn)部門制度
- 合作社生產(chǎn)作業(yè)制度
- 磁共振生產(chǎn)規(guī)章制度
- 生產(chǎn)管理架構(gòu)及管理制度
- 2025年手術(shù)室護理實踐指南知識考核試題及答案
- 彩禮分期合同范本
- 全民健身園項目運營管理方案
- 2025年松脂市場調(diào)查報告
- 2025年英語培訓(xùn)機構(gòu)學(xué)員合同示范條款協(xié)議
- 一年級地方課程教案
- SF-36評估量表簡介
- GB/T 10454-2025包裝非危險貨物用柔性中型散裝容器
- 河南省三門峽市2024-2025學(xué)年高二上學(xué)期期末調(diào)研考試英語試卷(含答案無聽力音頻及聽力原文)
- 睡眠科普課課件
- 2025年中遠(yuǎn)海運集團招聘筆試備考題庫(帶答案詳解)
評論
0/150
提交評論